In addition, spironolactone has a similar structure to progesterone and acts as a progesterone receptor (PR) agonist and androgen receptor (AR) antagonist, therefore promoting sexual side effects including gynecomastia and impotence in men and disruption of the menstrual cycle in women. The gene discussed is PGR; the disease is Gynecomastia.